Jack R Andrews

13PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 28, 2026
Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.

|Feb 21, 2025
Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single-Institution Pilot Study.

Cameron J Britton, Jack R Andrews, Ali Arafa

|Jan 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.

Jack R Andrews, Yohan Kim, Edlira Horjeti

|Oct 30, 2023
Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis.

Ahmed M Mahmoud, Daniel S Childs, Mohamed E Ahmed

|Nov 09, 2022
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer.

Jack R Andrews, Mohamed E Ahmed, Vidit Sharma

|Sep 12, 2022
Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis.

Jamal Alamiri, Cameron J Britton, Mohamed E Ahmed

Pageof 3

Frequent Collaborators

4 joint publications

Mohamed E Ahmed

3 joint publications

Ayca Dundar

1 joint publications

Brian J Linder

1 joint publications

Joseph A Scales